U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756138) titled 'Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex' on July 24.
Brief Summary: This pilot study will look at whether the topical Birch Triterpenes (Filsuvez) gel is safe and helpful for adults and children 6 months of age and older who have moderate to severe epidermolysis bullosa simplex (EBS). The study will examine whether the gel can reduce the number of blisters, help wounds heal faster, and improve comfort by reducing pain and itching and making daily activities easier.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Epidermolysis Bullosa Simplex
Intervention:
DRUG: Filsuvez
All the particip...